Safety and effectiveness of glucagon-like peptide-1 receptor agonists in inflammatory bowel disease
In this narrative literature review, we explore the pharmacological properties of tirzepatide and critically summarize and comment on the results of the clinical studies conducted thus far, as well as discuss the potential implications for the treatment of obesity, T2DM, and associated cardiometabolic complications
Recent research shows that GLP-1 medications help lowerinflammation, leading to fewer flares, less joint pain and stiffness, better movement, and more energy
Each GLP-1 product has specific guidance in its PIL about whether the pen needs to reach room temperature before use and how long this should take
When GLP-1 is boosted, weight loss efforts can often feel more manageable and sustainable
In many ways, your microbiome acts like a metabolic control panel influencing hunger, satiety, and energy regulation